Preparation H Hydrocortisone

Quick links

Choose a section

Quick links to important sections

Advertisements
Advertisements

Overview of Preparation H Hydrocortisone

Property Description
Active Ingredient Hydrocortisone
Form Topical Cream (Rectal Cream)
Pharmacological Class Corticosteroid (Glucocorticoid)
General Purpose Reduction of localized inflammation and itching
Origin Synthetic (Steroid hormone derivative)

What Type of Medicine is Preparation H Hydrocortisone?

Preparation H Hydrocortisone is a specialized topical cream whose medicinal core is the single active ingredient Hydrocortisone. This substance is a powerful, synthetic derivative belonging to the corticosteroid pharmacological class. Hydrocortisone is classified as a glucocorticoid, indicating its structural and functional similarity to the body's natural steroid hormones. Its formulation is specifically designed for localized, non-systemic delivery. This product positioning focuses on targeted relief for affected anorectal tissues, a characteristic distinguishing its intended use from general topical steroid creams.

Composition and General Purpose of the Topical Cream

The preparation's composition features Hydrocortisone suspended within a specialized cream base, making it an effective delivery system for localized treatment. The general purpose of this formulation is to swiftly and directly alleviate the primary symptoms associated with local tissue irritation and inflammation. As a potent anti-inflammatory agent, its primary benefit is the rapid reduction of swelling and inflammation, which also eliminates the intense pruritus (itching) that often accompanies such irritation. Hydrocortisone provides anti-inflammatory and antipruritic actions, calming irritated tissue and easing uncomfortable itching, a typical neutral use scenario for which the cream base is uniquely suited for topical application.

Regulatory References

  1. National Institutes of Health (NIH)
Advertisements

What side effects are possible with Preparation H Hydrocortisone?

Possible Side Effects and Safety Information

The safety profile for hydrocortisone topical cream, the active ingredient in Preparation H Hydrocortisone, is organized into expected local reactions and potential, typically rare, systemic effects, as documented in regulatory sources.

Adverse Reaction Classifications

Side effects are categorized based on the organ systems affected and their official frequency classification:

  • Common Reactions (Localized): Reactions reported at the application site are the most common adverse events. These include sensations such as burning, itching, irritation, dryness, and redness (erythema).
  • Rare Reactions (Systemic): More serious effects are rare and are primarily associated with the Endocrine System due to systemic absorption following prolonged or extensive use. These include Hypothalamic-Pituitary-Adrenal (HPA) axis suppression and manifestations resembling Cushing’s syndrome.

Safety Considerations by System-Organ Class

The adverse reactions are grouped into official system-organ classes, including Skin and Subcutaneous Tissue Disorders (e.g., skin atrophy, striae, folliculitis) and Endocrine Disorders.

Duration- and Population-Related Safety Patterns

The official labeling notes that the risk of adverse effects is related to the duration and manner of use:

  • Time-Related Risk: Effects such as skin atrophy and striae (stretch marks) are explicitly documented as having an increased risk with prolonged exposure. Local irritation may be more noticeable at the start of treatment.
  • Pediatric Safety: Pediatric patients are identified as having a specific safety consideration due to an increased susceptibility to systemic toxicity (such as HPA axis suppression) compared to adults, related to their larger skin surface area-to-body weight ratio.

The regulatory safety data emphasizes that while localized reactions are common, the more serious, rare effects are largely restricted to contexts involving extended exposure or application to compromised skin.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information emphasizes that there is no specific overdosage syndrome immediately associated with the use of topical hydrocortisone. However, the primary risks are related to accidental oral ingestion and prolonged overuse.

Risks and Systemic Exposure

Overdose risk is tied to using too much of the medicine, using it for a long time, or applying it to a large surface area. This can potentially lead to systemic absorption of the hydrocortisone, increasing the risk of adrenal gland problems or suppression of the hypothalamic-pituitary-adrenal (HPA) axis.

Documented symptoms of potential systemic exposure include:

  • Blurred vision
  • Dizziness or fainting
  • A fast, irregular, or pounding heartbeat
  • Unusual tiredness or weakness

Population-Specific Risk: The risk of adrenal gland problems is greater for children, who may absorb large amounts through the skin, potentially leading to serious side effects like HPA-axis suppression and growth retardation.

When to Seek Emergency Medical Help

Immediate medical help is required in the following situations:

  • If the product is swallowed, contact a Poison Control Center or get medical help right away. Acute oral overdose treatment may involve dilution with fluids.
  • If symptoms of adrenal gland problems develop (such as unusual tiredness, dizziness, or blurred vision) while using the medicine, check with a healthcare provider right away, as this may indicate excessive absorption from overuse.
Advertisements

Therapeutic Uses of Preparation H Hydrocortisone

The therapeutic scope of this cream is relevant when supportive symptom management is appropriate for conditions associated with localized inflammation and pruritus. This preparation is used across therapeutic domains where short-term symptomatic assistance is needed to ease distressing symptoms linked to inflammatory or irritative states.

The conditions in which this topical preparation is commonly used include external hemorrhoids, pruritus ani (anal itching), and minor skin irritations in the perianal area.

Targeting Acute Symptoms and Discomfort

This preparation is used in situations involving symptoms related to inflammatory or irritative states, primarily addressing symptoms that create noticeable physiological strain, like swelling, redness, soreness, and burning, characteristic of acute episodes. It is commonly used across conditions presenting with acute episodes, providing symptomatic relief for the most bothersome physical symptoms. The cream is also relevant for easing symptoms related to inflammatory or irritative states, especially intense pruritus that often accompanies anorectal discomfort. By offering symptomatic relief, the product supports patients during episodes of heightened discomfort and supports general well-being during symptomatic phases where symptoms that interfere with daily functioning become more disruptive during flare-ups.

Regulatory References

  1. NIH DailyMed Label for Hydrocortisone Cream
Advertisements

Eligibility and Restrictions for Use

Official Eligibility and Contraindications

The eligibility for using Preparation H Hydrocortisone (Hydrocortisone 1% Topical Cream) is strictly defined by regulatory documents, primarily based on age, local skin condition, and systemic risk factors.

Category Regulatory Status Description
Populations Allowed Adults and children 12 years of age and older Approved for use under standard labeled conditions for temporary relief.
Age Restriction Children under 12 years of age The over-the-counter (OTC) label explicitly states: "do not use, consult a doctor."
Absolute Contraindications Hypersensitivity and Untreated Local Infection Must not be used by patients with a known allergy to any component or in the presence of untreated bacterial, viral, or fungal infections at the site of application.
Specific Prohibition Diaper Rash Treatment The product is explicitly labeled with the instruction: "Do not use for the treatment of a diaper rash; consult a doctor."
Pregnancy Eligibility Conditional Use (Category C) Topical use during pregnancy should be considered only if the potential benefit justifies the potential risk; extensive or prolonged use is restricted.
Lactation Eligibility Restricted Use/Caution Caution should be exercised in nursing mothers; use is conditional on minimizing systemic absorption.
Special Caution Pediatric Patients (General) Children may have greater susceptibility to systemic effects like HPA axis suppression due to a larger skin surface-to-body weight ratio. Administration must be limited to the least amount compatible with an effective regimen.

Connection to the overall eligibility profile

Regulatory documents establish clear age-based permissions and define absolute contraindications concerning allergies and the presence of untreated infections. Eligibility for vulnerable populations, such as pregnant or nursing women and all pediatric patients, is conditional, requiring strict adherence to prescribed limitations to manage the documented risk of systemic absorption of the topical corticosteroid.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Preparation H Hydrocortisone, which contains the corticosteroid Hydrocortisone, is primarily determined by the potential for systemic absorption of the active ingredient, as detailed in regulatory documents.

Pharmacodynamic Interaction Patterns

The official labeling for corticosteroids addresses interactions that can lead to reinforced effects or increased toxicity when systemic absorption occurs. These interactions are categorized as pharmacodynamic, meaning they result from the combined effect of the two substances on the body:

  • Potassium-depleting agents: Co-administration with medicines classified as potassium-depleting agents, such as certain diuretics, may increase the risk of developing hypokalemia (low potassium levels).
  • Amphotericin B injection: Concomitant use with this medicine has been formally associated with severe outcomes, including reports of cardiac enlargement and congestive heart failure.
  • Neuromuscular blocking drugs: The combined use of high-dose corticosteroids and certain neuromuscular blocking drugs, such as pancuronium, has been linked to the development of acute myopathy (muscle damage).

Exposure-Augmenting Constraints

Conditions that increase the systemic exposure of topical hydrocortisone can heighten the potential relevance of these interactions. Regulatory information identifies specific constraints:

  • Increased Systemic Absorption: Application under occlusive dressings, use over large surface areas, or prolonged use increases systemic absorption, thereby augmenting the potential for the aforementioned systemic interactions.
  • Population Note: Due to a higher surface area-to-body mass ratio, pediatric patients may absorb proportionally larger amounts of the corticosteroid, which increases the risk for systemic exposure and subsequent interactions.
Advertisements

Mechanism of Action

The action of Hydrocortisone is based on its core role as a glucocorticoid that engages several complex cellular and molecular pathways to locally regulate the inflammatory response. Its mechanism is primarily genomic, meaning it works at the level of gene expression to alter the production of inflammatory and vascular mediators.

Hydrocortisone functions as an agonist for the intracellular Glucocorticoid Receptor (GR). The activated complex enters the nucleus and performs transrepression, which extensively suppresses the function of pro-inflammatory transcription factors like NF-kappa B. This blocks the cell's ability to synthesize a wide range of proteins and signals (such as IL-1, IL-6, TNF-alpha) that normally drive the inflammatory response.

Simultaneously, the drug performs transactivation, increasing the synthesis of the anti-inflammatory protein Annexin A1. Annexin A1 then inhibits the enzyme Phospholipase A2 ( PLA2), which is essential for initiating the Arachidonic Acid Cascade. This interruption prevents the formation of downstream inflammatory mediators like prostaglandins and leukotrienes, resulting in diminished sensitization of C-fiber nociceptors.

The resulting absence of vasodilatory mediators allows for the stabilization of local vascular tone, leading to vasoconstriction and a critical decrease in capillary permeability. This physiological change reduces fluid and plasma protein extravasation into the irritated tissue, limiting the physiological events that contribute to local tissue swelling.

Advertisements

Dosage and Administration Information

How to Use Preparation H Hydrocortisone

This section describes the administration and dosing regimen for topical Hydrocortisone 1% cream.


Administration Scope

Property Official Instruction
Route of Administration The preparation is for Topical application only, restricted to the external affected area.
Dosing Schedule Apply a small amount to the affected external area of the skin.
Frequency & Duration Application is limited to not more than 3 to 4 times daily and should not exceed a maximum self-treatment course of seven days.

Procedural and Population Rules

Official labeling defines specific procedural requirements that govern the use of this topical cream.

Prior to each application, the affected area must be cleansed and gently dried (by blotting or patting), establishing a necessary preparatory step for proper administration. The usage is strictly confined to the external surface; the cream must not be inserted into the rectum using fingers or any mechanical applicator.

Regimens are specified for adults and children 12 years of age and older. Use in children under 12 years of age requires consultation with a healthcare professional before administration.

This structured protocol reinforces the non-systemic delivery model, defining the boundaries of short-term, external use with a mandated frequency and duration.

Advertisements

Recent Clinical Evidence

Recent Clinical Evidence

Overview of Investigational Therapy Research

Research has explored the role of hydrocortisone, an anti-inflammatory corticosteroid, for the temporary relief of external anal itching associated with hemorrhoids. Hydrocortisone acetate is the active ingredient used in Preparation H Hydrocortisone. The use of low-strength, over-the-counter (OTC) hydrocortisone for this indication is based on its established mechanism for reducing inflammation.

The main body of evidence, according to available data, focuses on the local anti-inflammatory action of topical hydrocortisone. Studies included participants with external symptoms, evaluating the duration and degree of temporary relief experienced compared to a baseline or placebo.

Study Type Primary Focus
Topical Application Data Rate of skin penetration and local effect
Symptom Reduction Trials Temporary decrease in itching severity and discomfort

Safety Profile and Use

In clinical research and regulatory evaluations, the safety profile was assessed in adult participants using the labeled concentration of hydrocortisone. The trials included participants who self-reported mild to moderate external hemorrhoidal symptoms. The goal of the research was to confirm the temporary relief properties of the low-strength corticosteroid.

The research summarized here describes the findings of specific clinical data supporting the use of hydrocortisone for external anal itching. It does not provide medical guidance or recommendations for individual treatment. Consulting a healthcare professional is necessary for persistent symptoms or concerns.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Preparation H Hydrocortisone (FAQ)


Q: Does Preparation H Hydrocortisone work for other skin issues besides hemorrhoids?

A: The active ingredient, hydrocortisone, is officially indicated for the temporary relief of inflammatory and itchy skin conditions that are responsive to corticosteroids. Regulatory documents specify that this product is for the labeled use only. Official labeling includes a specific prohibition against using the cream to treat diaper rash.

Q: Why does Preparation H Hydrocortisone have a warning about using it for more than seven days?

A: The self-treatment duration is limited to seven days because the risk of certain side effects is documented to increase with prolonged exposure. Official labeling highlights that extended use may lead to rare systemic effects, such as the suppression of the hypothalamic-pituitary-adrenal (HPA) axis, which is a hormonal effect.

Q: Can Preparation H Hydrocortisone cause skin thinning with short-term use?

A: Skin thinning, or atrophy, is a documented potential side effect of topical corticosteroids. However, official safety data indicates that the risk of this and other more serious skin reactions is specifically associated with, and increases with, prolonged exposure rather than the recommended short-term use.

Q: Is Preparation H Hydrocortisone safe to use if I have diabetes?

A: Caution is advised regarding the use of topical hydrocortisone for patients with pre-existing conditions like diabetes. This is because there is a potential for some systemic absorption of the corticosteroid to cause or worsen high blood sugar levels.

Q: Is there any difference in how effective the cream is versus the ointment form, if both contain hydrocortisone?

A: While the active ingredient, hydrocortisone, is the same regardless of the form, regulatory information shows that the vehicle—such as a cream base versus an ointment base—can affect how the medication is absorbed by the skin. Differences in the vehicle are noted in regulatory information as potentially influencing the overall potency or absorption of the product.

Q: Are there research studies comparing hydrocortisone products to non-medicated options for this purpose?

A: Official clinical summaries confirm that research has been conducted on the temporary symptom relief provided by the hydrocortisone product. These studies evaluated the product’s effectiveness by comparing the results to baseline symptoms or a non-medicated placebo.

Q: What kind of sensation is considered 'normal' when first applying the cream?

A: Localized burning, itching, or irritation are listed in official documents as common reactions to this medication. Regulatory information notes that local irritation may be more noticeable when treatment is first initiated.

Q: Is there a known link between Preparation H Hydrocortisone use and changes in blood pressure?

A: While rare, systemic absorption of the corticosteroid can potentially lead to serious hormonal effects, such as manifestations resembling Cushing’s syndrome. High blood pressure is described in official regulatory monographs as a sign associated with this systemic effect, though this occurs primarily with extensive or prolonged use.

Q: Do experts recommend taking any specific precautions when using this product for the first time?

A: Official instructions state that the affected area should be cleansed and gently dried (by blotting or patting) prior to each application. This preparatory step is consistent regardless of whether it is the first or subsequent application.

Q: Can I use Preparation H Hydrocortisone if I am currently using a topical antifungal cream?

A: The combination of topical corticosteroids and antifungal agents is a known therapeutic strategy for certain skin conditions. However, official labeling does not provide specific guidance on co-administration with other over-the-counter topical products.

Q: Why do official documents mention not using it on broken or infected skin?

A: Official documents caution against using the cream on broken or infected skin. This is because using the product over compromised tissue can increase the risk of side effects due to enhanced systemic absorption, or it may potentially worsen an existing infection.

Q: What type of ingredients are used alongside hydrocortisone in the Preparation H formula?

A: The Preparation H Hydrocortisone formula contains the active ingredient hydrocortisone, along with several inactive ingredients that make up the cream base. Official product monographs list these inactive ingredients, which commonly include emollients (like mineral oil and petrolatum), stabilizers, and preservatives.

Q: What are the circumstances under which someone should stop using the cream and see a doctor?

A: Official product information states that the product should be discontinued if the condition worsens or if symptoms persist for more than seven days. Consultation with a healthcare professional is noted as the appropriate action in these circumstances, or if the symptoms clear up and then occur again within a few days.

Q: Can Preparation H Hydrocortisone affect the results of blood or urine tests?

A: The possibility of systemic absorption means the corticosteroid could potentially affect the results of certain hormonal tests. Official regulatory information mentions the potential influence on laboratory tests, such as the urinary free cortisol test, which is used to measure adrenal function.

Q: What are the ingredients listed as inactive in the Preparation H Hydrocortisone formula?

A: The Preparation H Hydrocortisone formula contains the active ingredient hydrocortisone, along with several inactive ingredients that make up the cream base. Official product monographs list these inactive ingredients, which commonly include emollients (like mineral oil and petrolatum), stabilizers, and preservatives.

Q: Does the package insert include information about potential withdrawal symptoms after stopping use?

A: Regulatory safety data indicates that the reversal of HPA axis suppression is typically prompt upon discontinuing the drug. Concerns regarding dependence or potential withdrawal symptoms are generally advised to be directed to a healthcare professional.

Q: Why might a doctor prescribe a stronger hydrocortisone product instead of recommending the OTC option?

A: Low-strength over-the-counter hydrocortisone products are primarily intended for mild, temporary symptoms. Physicians may select stronger, higher-potency corticosteroid products for patients with conditions that are more severe, resistant to treatment, or chronic.

Q: What does the term 'anti-inflammatory' mean for the user of this medication?

A: The anti-inflammatory action of this medication means it works by suppressing the body’s natural inflammatory signals at the application site. According to regulatory texts, this process leads to a reduction in redness, heat, and swelling in the affected area.

Advertisements

How should Preparation H Hydrocortisone be stored and disposed of?

The storage and disposal of Preparation H Hydrocortisone cream must adhere strictly to regulatory conditions to ensure stability and safety.

Requirement Area Official Labeled Condition
Temperature & Protection Store at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F). Protect from freezing, excess heat, moisture, and direct light.
Container Rule Keep the cream in the container it came in, tightly closed. Do not use the product if the seal has been broken.
Child Safety Keep out of the sight and reach of children. If swallowed, contact with a Poison Control Center or immediate medical help is required.
Disposal Do not keep outdated medicine. Ask a healthcare professional how to dispose of any medicine that is not used.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Preparation H Hydrocortisone found in:

A-Z Index: